Topical Dermatologic Corticosteroids: in Vivo Bioequivalence

Issue Date: June 2, 1995
Issued by: Center for Drug Evaluation and Research
Topic(s): Biopharmaceutics, Generic Drugs
Status: Final

Topical Dermatologic Corticosteroids: in Vivo Bioequivalence

This guidance provides recommendations to pharmaceutical sponsors on methods to document in vivo bioequivalence of topical dermatologic corticosteroids, hereinafter referred to as topical corticosteroids.

Download the Guidance Document

webmaster1995-06-02T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.